| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/21/2007 | CA2633063A1 Cell penetrating peptide conjugates for delivering of nucleic acids intocells |
| 06/21/2007 | CA2633033A1 Annexin derivatives suitable for pretargeting in therapy and diagnosis |
| 06/21/2007 | CA2632831A1 Powder formulations for use in dry powder inhalers |
| 06/21/2007 | CA2631391A1 Aqueous-alcoholic depigmenting gel |
| 06/21/2007 | CA2630990A1 Method for deriving a wellness related index for a food composition |
| 06/21/2007 | CA2630399A1 Production of conjugates |
| 06/20/2007 | EP1798285A1 Methods and medicament for inhibition the expression of a defined gene |
| 06/20/2007 | EP1798241A1 Method of manufacturing a hapten between doxycycline and bovine serum albumin and application for detecting doxycycline in humans or animals |
| 06/20/2007 | EP1797902A2 Particles for inhalation having sustained release properties |
| 06/20/2007 | EP1797901A1 Cell penetrating peptide conjugates for delivering nucleic acids into cells |
| 06/20/2007 | EP1797900A1 Preparation for percutaneous/permucosal absorption |
| 06/20/2007 | EP1797893A2 New composition |
| 06/20/2007 | EP1797881A1 Medicinal composition |
| 06/20/2007 | EP1797874A1 Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation |
| 06/20/2007 | EP1797873A2 Compressed microparticles for dry injection |
| 06/20/2007 | EP1797871A1 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
| 06/20/2007 | EP1797870A1 Oral delivery of protein drugs using microemulsion |
| 06/20/2007 | EP1797869A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 06/20/2007 | EP1797127A2 Modified fc molecules |
| 06/20/2007 | EP1796749A1 Resorbable ceramic compositions |
| 06/20/2007 | EP1796731A2 Endogenously-formed conjugate of albumin |
| 06/20/2007 | EP1796730A2 Stabilized leukotriene b4 (ltb4) agent pharmaceutical |
| 06/20/2007 | EP1796729A1 Liposomes with improved drug retention for treatment of cancer |
| 06/20/2007 | EP1796721A1 Cancerous disease modifying antibodies |
| 06/20/2007 | EP1796718A2 Therapeutic agents with decreased toxicity |
| 06/20/2007 | EP1796676A2 Transdermal administration of phycotoxins |
| 06/20/2007 | EP1796668A1 Aqueous pharmaceutical preparation comprising roflumilast |
| 06/20/2007 | EP1796647A2 Stable pegylated interferon formulation |
| 06/20/2007 | EP1796635A2 D-methionine formulation with improved biopharmaceutical properties |
| 06/20/2007 | EP1796629A2 Semi-solid delivery vehicle and pharmaceutical compositions |
| 06/20/2007 | EP1796626A1 Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants |
| 06/20/2007 | EP1796625A2 Novel fenofibrate formulations and related methods of treatment |
| 06/20/2007 | EP1796624A2 Use of a viscoelastic composition for treating increased intraocular pressure |
| 06/20/2007 | EP1796613A1 Transdermal delivery of hydrophobic bioactive agents |
| 06/20/2007 | EP1796537A2 Dendrimer based compositions and methods of using the same |
| 06/20/2007 | EP1715887B1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and use thereof |
| 06/20/2007 | EP1684723A4 Contrast medium comprising liposomes containing hydrophobic chelate compound |
| 06/20/2007 | EP1675888B1 Cationic polymers having degradable crosslinks |
| 06/20/2007 | EP1663186B1 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1406946B1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 06/20/2007 | EP1379254B1 Use of bile acid or bile salt fatty acid conjugates |
| 06/20/2007 | EP1324760B1 Creatine ester pronutrient compounds and formulations |
| 06/20/2007 | EP1154796B1 Novel albumin-free factor viii formulations |
| 06/20/2007 | EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | EP0605477B2 Gaseous ultrasound contrast media |
| 06/20/2007 | CN1984935A Novel temperature and PH sensitive copolymers |
| 06/20/2007 | CN1984924A Methods for increasing conjugation of protein and polyethylene glycol (PEG) |
| 06/20/2007 | CN1984682A Solid medicinal preparation |
| 06/20/2007 | CN1984679A Methods for preparing immunogenic conjugates |
| 06/20/2007 | CN1984675A Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose |
| 06/20/2007 | CN1984674A Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 06/20/2007 | CN1984673A Hydrogel interferon formulations |
| 06/20/2007 | CN1984661A Controlled-release formulations containing vardenafil |
| 06/20/2007 | CN1984644A Stabilised supersaturated solid solutions of steroidal drugs |
| 06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
| 06/20/2007 | CN1981871A Elemene externally-applied preparation and its use |
| 06/20/2007 | CN1981870A Invert-sugar powdery injection and its production |
| 06/20/2007 | CN1981780A Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/20/2007 | CN1981765A Medicament composition of cefpodoxime proxetil and cyclodextrin and preparation method thereof |
| 06/20/2007 | CN1981747A Rapidly disintegrating methylcellulose tablets |
| 06/20/2007 | CN1981743A Colon positioned releasing micropills and production thereof |
| 06/20/2007 | CN1981742A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/20/2007 | CN1981739A Esmolol preparation |
| 06/20/2007 | CN1981738A Stomach resorting agent of cephalosporin and preparation method thereof |
| 06/20/2007 | CN1322016C Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 06/20/2007 | CN1322013C Soluble high branched glucose polymer and its producing process |
| 06/20/2007 | CN1321958C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/20/2007 | CN1321696C Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321633C Treatment of nail infections using NO generating compositions |
| 06/20/2007 | CN1321629C Tablets having improved tabletting characteristics and process for producing the same |
| 06/20/2007 | CN1321628C Wet milling process |
| 06/19/2007 | US7232879 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 06/19/2007 | US7232805 Cobalamin conjugates for anti-tumor therapy |
| 06/19/2007 | US7232803 Molecule comprising backbone of 2-35 non-hydrogen atoms in length, having covalently attached bulky lipoophilic groups and having more cationic than anionic moiety in manufacturing medicament for destabilising microbial cell membranes |
| 06/19/2007 | US7232802 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/19/2007 | US7232684 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 06/19/2007 | US7232577 Readily dispersible dietary fiber composition |
| 06/19/2007 | US7232575 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 06/19/2007 | US7232574 Uniform distribution of a long chain alcohol such as policosanol or octacosanol in a food by dissolving or suspending the alcohol in an edible oil containing less than 12 weight % linolenic acid that is free of C8-10 fatty acid triglycerides and combining the product with the food; emulsifier-free |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2316888C Methods of inactivating bacteria including bacterial spores |
| 06/19/2007 | CA2276429C Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 06/19/2007 | CA2187741C Colon-specific drug release system |
| 06/19/2007 | CA2182939C A rapidly disintegrating medicinal form of tramadol or a tramadol salt |
| 06/19/2007 | CA2138850C Calcium-modified oxidized cellulose hemostat |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/16/2007 | CA2571103A1 Seeding cells on porous supports |
| 06/14/2007 | WO2007067602A1 Interleukin-11 compositions and methods of use |
| 06/14/2007 | WO2007067582A2 Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| 06/14/2007 | WO2007066832A1 Emulsified composition |
| 06/14/2007 | WO2007066781A1 Process for producing pharmaceutical composition containing drug-encapsulating polymer micelle using fluorine-containing organic solvent |
| 06/14/2007 | WO2007066773A1 Isohumulone compound clathrate and composition containing the same |
| 06/14/2007 | WO2007066744A1 Method of improving absorbability of epigallocatechin, food, drink and food/drink material using the same and method of producing the same |
| 06/14/2007 | WO2007066646A1 Process for producing tablet by high-speed direct compression |
| 06/14/2007 | WO2007066151A2 Topical compositions for treatment of respiratory disorders |
| 06/14/2007 | WO2007066150A2 Transdermal administration of active agents for systemic effect |